Sargent Bickham Lagudis LLC Ark Genomic Revolution ETF (De Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 435 shares of ARKG stock, worth $9,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
435
Previous 435
-0.0%
Holding current value
$9,852
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
23.4MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$82.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$78.9 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$63.2 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$63 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$37.5 Million0.02% of portfolio